FibroBiologics, Inc. (FBLG)
NASDAQ: FBLG · Real-Time Price · USD
1.330
+0.010 (0.76%)
At close: Apr 1, 2026, 4:00 PM EDT
1.306
-0.024 (-1.80%)
After-hours: Apr 1, 2026, 7:59 PM EDT
FibroBiologics Stock Forecast
FBLG's stock price has decreased by -92.61% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 1 analyst with a 12-month price forecast for FibroBiologics stock has a target of 80, which predicts a 5,915.04% increase from the current stock price of 1.33.
Price Target: $80 (+5,915.04%)
Analyst Consensus: Buy
* Price targets were last updated on Feb 26, 2026.
Analyst Ratings
The average analyst rating for FibroBiologics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 3 | 3 | 2 | 2 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 3 | 3 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| D. Boral Capital | D. Boral Capital | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Mar 26, 2026 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $140 | Strong Buy | Maintains | $140 | +10,426.32% | Mar 12, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $100 → $80 | Strong Buy | Maintains | $100 → $80 | +5,915.04% | Feb 26, 2026 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $300 → $140 | Strong Buy | Maintains | $300 → $140 | +10,426.32% | Feb 25, 2026 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $300 | Strong Buy | Maintains | $300 | +22,456.39% | Jan 6, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-0.25
from -8.35
EPS Next Year
-0.27
from -0.25
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | n/a | n/a | |||
| Avg | n/a | n/a | |||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | -0.18 | -0.17 | |||
| Avg | -0.25 | -0.27 | |||
| Low | -0.28 | -0.37 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.